Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2015 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies to Present at the 2015 UBS Global Healthcare Conference

NEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS")...
May 07, 2015 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

NEW YORK, May 7, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS")...
April 30, 2015 07:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Reports First Quarter 2015 Financial Results and Provides Corporate Update

NEW YORK, April 30, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
April 24, 2015 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies to Host First Quarter 2015 Financial Results Conference Call and Webcast

NEW YORK, April 24, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
March 31, 2015 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program at the 15th International Congress on Schizophrenia Research

NEW YORK, March 31, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
March 25, 2015 08:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies to Present at the 15th International Congress on Schizophrenia Research

NEW YORK, March 25, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
March 12, 2015 07:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2014 Financial Results and Provides Corporate Update

NEW YORK, March 12, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
March 11, 2015 16:01 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares

NEW YORK, March 11, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced the completion of its previously announced underwritten public...
March 05, 2015 21:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock

NEW YORK, March 5, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced the pricing of its previously announced underwritten public...
March 04, 2015 07:00 ET | Source: Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

NEW YORK, March 4, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of...